Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
Open Access
- 22 September 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (46), 7205-7212
- https://doi.org/10.1016/j.vaccine.2020.09.058
Abstract
No abstract availableFunding Information
- Medical Center, University of Pittsburgh
This publication has 30 references indexed in Scilit:
- National common metrics for the NIH Clinical and Translational Science Award Institutions: A signal of the transformation of the American biomedical research enterpriseJournal of Clinical and Translational Science, 2019
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- Fc receptors in antibody‐dependent enhancement of viral infectionsImmunological Reviews, 2015
- Receptor-binding domain as a target for developing SARS vaccines2013
- Dengue Virus Neutralization in Cells Expressing Fc Gamma ReceptorsPLOS ONE, 2013
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS VirusPLOS ONE, 2012
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza VirusScience Translational Medicine, 2010
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- The Secret Life of ACE2 as a Receptor for the SARS VirusCell, 2003
- Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virusVirus Research, 1986